Induction of FosB/ΔFosB in the brain stress system-related structures during morphine dependence and withdrawal

Journal of Neurochemistry

Volumn 114, Issue 2, 2010, Pages 475-487

  Núñez, Cristina ^a   Martín, Fátima ^a   Földes, Anna ^b   Luisa Laorden, M ^a   Kovács, Krisztina J ^b   Victoria Milanes M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

brain stress system; corticotropin releasing factor; dynorphin; FosB FosB; morphine; tyrosine hydroxylase

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MORPHINE; NALOXONE; PRODYNORPHIN; SODIUM CHLORIDE; TRANSCRIPTION FACTOR DELTA FOSB; TRANSCRIPTION FACTOR FOSB; TYROSINE 3 MONOOXYGENASE; DYNORPHIN; ENKEPHALIN; FOSB PROTEIN, RAT; PREPROENKEPHALIN; PROTEIN C FOS; PROTEIN PRECURSOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN NERVE CELL; BRAIN NUCLEUS; BRAIN REGION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLITARY TRACT NUCLEUS; STRESS; STRIA TERMINALIS; THALAMUS MIDLINE NUCLEUS; WESTERN BLOTTING; WITHDRAWAL SYNDROME; ANIMAL; BIOSYNTHESIS; BRAIN; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; WISTAR RAT;

RATTUS;

ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DYNORPHINS; ENKEPHALINS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MORPHINE; MORPHINE DEPENDENCE; PITUITARY-ADRENAL SYSTEM; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; STRESS, PHYSIOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 77953846458     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06765.x     Document Type: Article

References (50)

1. Aston-Jones G., Delfs J. M., Druhan J. Zhu Y. (1999) The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann. NY Acad. Sci. 877, 486 498.
2. Bhargava H. N. Gulati A. (1990) Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. J. Pharmacol. Exp. Ther. 252, 901 907.
3. Carrie L., Walters M. S., Aston-Jones G. Druhan J. P. (2000) Expression of Fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist. Neuropsychopharmacology 23, 307 315.
4. Chao J. Nestler E. J. (2004) Molecular neurobiology of drug addiction. Annu. Rev. Med. 55, 113 132.
5. Chen J. S., Nye H. E., Kelz M. B., Hiroi N., Nakabeppu Y., Hope B. T. Nestler E. J. (1995) Regulation of DFosB and FosB-like proteins by electroconvulsive seizure (ECS) and cocaine treatments. Mol. Pharmacol. 48, 880 889.
6. Chocyk A., Czyrak A. Wedzony K. (2006) Acute and repeated cocaine induces alterations in FosB/[Delta]FosB expression in the paraventricular nucleus of the hypothalamus. Brain Res. 1090, 58 68.
7. Cleck J. N. Blendy J. A. (2008) Making a bad thing worse: adverse effects of stress on drug addiction. J. Clin. Invest. 118, 454 461.
8. Contarino A. Papaleo F. (2005) The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opioid withdrawal. PNAS 102, 18649 18654.
9. Crespo J. A., Manzanares J., Oliva J. M., Corchero J., GarcÆa-Lecumberri C. Ambrosio E. (2003) Extinction of cocaine self-administration produces alterations in corticotropin releasing factor gene expression in the paraventricular nucleus of the hypothalamus. Mol. Brain Res. 117, 160 167.
10. Delfs J. M., Zhu Y., Druhan J. P. Aston-Jones G. (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403, 430 434.
11. Forray M. I. Gysling K. (2004) Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res. Rev. 47, 145 160.
12. Fuertes G., Laorden M. L. Milanés M. V. (2000) Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal. Neuroendocrinology 71, 60 67. (Pubitemid 30045336)
13. Goeders E. (2003) The impact of stress on addiction. Eur. Neuropsychopharmacol. 13, 435 441.
14. Heimer L. Alheid G. (1991) Piecing together the puzzle of basal forebrain anatomy. Adv. Exp. Med. Biol. 295, 1 42.
15. Koob G. F. (2006) The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101, 23 30.
16. Koob G. F. (2008) A role for Brain Stress System in addiction. Neuron 59, 11 34.
17. Koob G. Kreek M. J. (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry 164, 1149 1159.
18. Koob G. F. Le Moal M. (2001) Drug addiction, dysregulation of reward and allostasis. Neuropsychopharmacology 24, 97 129.
19. Koob G. F. Le Moal M. (2008) Neurobiological mechanisms for opponent motivational processes in addiction. Phil. Trans. R. Soc. B 363, 3113 3123.
20. Koob G. F. Volkow N. D. (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35, 217 238.
21. Koob G. F., Sanna P. P. Bloom F. E. (1998) Neuroscience of addiction. Neuron 21, 467 476.
22. Kreek M. J. Koob G. F. (1998) Drug dependence: stress and dysregulatioon of brain reward pathways. Drug Alcohol Depend. 51, 23 47.
23. 2-adrenoceptors. J. Pharmacol. Exp. Ther. 293, 578 584.
24. Laorden M. L., Castells M. T. Milanés M. V. (2002a) Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats. Br. J. Pharmacol. 136, 67 75.
25. Laorden M. L., Núñez C., Almela P. Milanés M. V. (2002b) Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones. J. Neurochem. 83, 132 140.
26. Le Moal M. Koob G. F. (2007) Drug addiction: pathways to the disease and pathophysiological perspectives. Eur. Neuropsychopharmacol. 17, 377 393.
27. McClung C. A., Ulery P. G., Perrotti L. I., Zachariou V., Berton O. Nestler E. J. (2004) [Delta]FosB: a molecular switch for long-term adaptation in the brain. Mol. Brain Res. 132, 146 154.
28. McClung C. A., Nestler E. J. Zachariou V. (2005) Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J. Neurosci. 25, 6005 6015.
29. Moratalla R., Elibol B., Vallejo M. Graybiel A. M. (1996) Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147 156.
30. Mumberg D., Lucibello F. C., Schuermann M. Muller R. (1991) Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5, 1212 1223.
31. Navarro-Zaragoza J., Núñez C., Laorden M. L. Milanes M. V. (2010) Effects of corticotropin-releasing factor receptor-1 (CRF1R) antagonists on the brain stress system responses to morphine withdrawal. Mol. Pharmacol. 77, 864 873.
32. Nestler E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119 128.
33. Nestler E. J. (2008) Transcriptional mechanisms of addiction: role of DFosB. Phil. Trans. R. Soc. B 363, 3245 3255.
34. Núñez C., Foldes A., Laorden M. L., Milanes M. V. Kovács K. J. (2007a) Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J. Neurochem. 101, 1060 1071.
35. 2 cell group. Role of ERK1/2. Endocrinology 148, 5780 5793.
36. Núñez C., Castells M. T., Laorden M. L. Milanes M. V. (2008) Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system. N-S Arch. Pharmacol. 378, 407 420.
37. Núñez C., Földes A., Pérez-Flores D., García-Borrón J. C., Laorden M. L., Kovács K. J. Milanés M. V. (2009) Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal. Endocrinology 150, 3118 3127.
38. Nye H. E. Nestler E. J. (1996) Induction of chronic fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636 645.
39. Olive M. F., Koenig H. N., Nannini M. A. Hodge C. W. (2002) Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 72, 213 220.
40. Palkovits M. Brownstein M. J. (1988) Maps and Guide to Microdissection of the rat Brain. Elsevier
41. Perrotti L. I., Hadeishi Y., Ulery P. G., Barrot M., Monteggia L., Duman R. S. Nestler E. J. (2004) Induction of {Delta}FosB in Reward-Related Brain Structures after Chronic Stress. J. Neurosci. 24, 10594 10602.
42. Perrotti L. I., Weaver R. R., Robison B. et al. (2008) Distinct patterns of FosB induction in brain by drugs of abuse. Synapse 62, 358 369.
43. Renthal W. Nestler E. J. (2008) Epigenetic mechanisms in drug addiction. Trends Mol. Med. 14, 341 350.
44. Renthal W., Carle T. L., Maze I., Covington III. H. E., Truong H. T., Alibhai I., Kumar A., Montgomery R. L., Olson E. N. Nestler E. J. (2008) {Delta}FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J. Neurosci. 28, 7344 7349.
45. Sawchenko P. E. Swanson L. W. (1982) The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. Rev. 4, 275 325.
46. Shippenberg T. S., Zapata A. Chefer V. I. (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 116, 306 321.
47. Sinha R. (2007) The role of stress in addiction relapse. Curr Psychiatry Rep. 9, 388 395.
48. Smith R. J. Aston-Jones G. (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct. 213, 43 61.
49. Wallace D. L., Vialou V., Rios L. et al. (2008) The influence of DFosB in the nucleus accumbens on natural reward-related behaviour. J. Neurosci. 28, 10272 10277.
50. Zachariou V., Bolanos C. A., Selley D. E. et al. (2006) An essential role for [Delta]FosB in the nucleus accumbens in morphine action. Nat. Neurosci. 9, 205 211.